Small differentiated thyroid cancer: Time to reconsider clinical management and treatment

Surgical Oncology

Volumn 21, Issue 4, 2012, Pages 257-262

  Momesso, Denise Prado ^a   Vaisman, Fernanda ^a,b   Cordeiro De Noronha Pessoa, Cencita Hosanah ^b   Corbo, Rossana ^a,b   Vaisman, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Differentiated thyroid cancer; Radioactive iodine therapy; Thyroidectomy

Indexed keywords

RADIOACTIVE IODINE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; DIFFERENTIATED THYROID CANCER; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE METASTASIS; MOLECULAR BIOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK FACTOR; SMALL DIFFERENTIATED THYROID CANCER; SURGICAL APPROACH; THYROIDECTOMY;

CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; DISEASE MANAGEMENT; HUMANS; THYROID NEOPLASMS;

EID: 84867868814     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2012.06.002     Document Type: Review

References (48)

1. L. Enewold, K. Zhu, E. Ron, A.J. Marrogi, A. Stojadinovic, and G.E. Peoples Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005 Cancer Epidemiol Biomarkers Prev 18 2009 784 792
2. L. Davis, and H.G. Welch Increasing incidence of thyroid cancer in the United States, 1973-2002 J Am Med Ass 295 2006 2164 2167
3. J.R. Burgess, and P. Tucker Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine- needle aspirate cytology Thyroid 16 2006 47 53
4. L. Leenhardt, P. Grosclaude, and L. Cherie-Challine Increased incidence rates of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Thyroid 14 2004 1056 1060
5. A. Lubina, O. Cohen, M. Barchana, I. Liphshiz, I. Vered, and S. Sadetzki Time trend of incidence of thyroid cancer in Israel: what might explain the sharp increase Thyroid 16 2006 1033 1040
6. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, and H.R. Menck A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the US 1985-1995 Cancer 83 1998 2638 2648
7. L.J. DeGroot, E.L. Kaplan, M. McCormick, and F.H. Strauss Natural history, treatment, and course of papillary thyroid carcinoma J Clin Endocrinol Metab 71 1990 414 424
8. I.D. Hay, M.E. Hutchinson, T. Gonzalez-Losada, B. McIver, M.E. Reinalda, and C.S. Grant Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period Surgery 144 2008 980 987
9. E.L. Mazzaferi Managing small thyroid cancers J Am Med Ass 295 2006 2179 2182
10. K.Y. Bilimoria, D.J. Bentrem, C.Y. Ko, A.K. Stewart, D.P. Winchester, and M.S. Talamonti Extent of surgery affects survival for papillary thyroid cancer Ann Surg 246 2007 375 384
11. J.A. van Heerden, I.D. Hay, J.R. Goellner, D. Salomao, J.R. Ebersold, and E.J. Bergstralh Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy Surgery 112 1992 1130 1136
12. M.R. Pelizzo, I.M. Boschin, A. Toniato, C. Pagetta, A. Piotto, and P. Bernante Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma: a mono-institutional 12 year experience Nucl Med Commun 25 2004 547 552
13. S.M. Chow, S.C. Law, J.K. Chan, S.K. Au, S. Yau, and W.H. Lau Papillary microcarcinoma of the thyroid- prognostic significance of lymph node metastasis and multifocality Cancer 98 2003 31 40
14. G. Pellegriti, C. Scollo, G. Lumera, C. Regalbuto, R. Vigneri, and A. Belfiori Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases J Clin Endocrinol Metab 89 2004 3713 3720
15. C.P. Lombardi, R. Bellantone, C. De Crea, N.C. Paladino, M. Salvatori, and M. Rafaelli Papillary thyroid microcarcinoma: extrathyroid extension, lymph node metastases and risk factors for recurrence in a high prevalence of goiter area World J Surg 34 2010 1214 1221
16. Y. Ito, H. Masuoka, M. Fukushima, H. Inoue, M. Kihara, and C. Tomoda Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy World J Surg 34 2010 1285 1290
17. X.M. Yu, Y. Wan, R.S. Sippel, and H. Chen Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases Ann Surg 254 2011 653 660
18. L. Zhang, W.J. Wei, Q.H. Ji, Y.X. Zhu, Z.Y. Wang, and Y. Wang Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients J Clin Endocrinol Metab 97 2012 1250 1257
19. T.M. Shattuck, W.H. Westra, P.W. Ladenson, and A. Arnold Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma N Engl J Med 352 2005 2406 2412
20. M. Fukushima, Y. Ito, M. Hirokawa, A. Miya, K. Shimizu, and A. Miyauchi Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma Word J Surg 34 2010 3007 3017
21. M. Xing, W.H. Westra, R.P. Tufano, Y. Cohen, E. Rosenbaum, and K.J. Rhoden BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 2005 6373 6379
22. G.M. Howell, S.E. Carty, M.J. Armstrong, S.O. Lebeau, S.P. Kodak, and C. Coyne Both BRAF V600E mutation and older age (>65 years) are associated with recurrent papillary thyroid cancer Ann Surg Oncol 18 2011 3566 3571
23. Y.E. Nikiforov, D.L. Steward, T.M. Robinso-Smith, B.R. Haugen, J.P. Klopper, and Z. Zhu Molecular testing for mutations in improving the fine- needle aspiration diagnosis of thyroid nodules J Clin Endocrinol Metab 94 2009 2092 2098
24. S. Cantara, M. Capezzone, S. Marchisotta, S. Capuano, G. Busonero, and P. Toti Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology J Clin Endocrinol Metab 95 2010 1365 1369
25. M. Xing, D. Clark, H. Guan, M. Ji, A. Dackiw, and A. Carson BRAF mutation testing of thyroid fine- needle asporation biopsy specimens for preoperative risk stratification in papillary thyroid cancer J Clin Oncol 27 2009 2977 2982
26. C. Wittekind, C.C. Compton, F.L. Greene, and L.H. Sobin TNM residual tumor classification revisited Cancer 94 2002 2511 2516
27. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W.A. Smit, W. Wiersinga The European Taskforce European consensus for the management of patients with differentiated thyroid cancer of the follicular epithelium Eur J Endocrinol 154 2006 787 803
28. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.T. Lee, and S.J. Manden Revised American Thyroid Association management guidelines for patient with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1213
29. A.L. Maia, L.S. Ward, G.A. Carvalho, H. Graff, R.M.B. Maciel, and L.M.Z. Maciel Thyroid nodules and differentiated thyroid cancer: Brazilian consensus Arq Bras Endocrinol Metab 51 2007 867 873
30. F. Pitoia, L. Ward, N. Wohllk, C. Friguglietti, E. Tomimori, and A. Gauna Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer Arq Bras Endocrinol Metabol 53 2009 884 887
31. A.R. Shaha Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer Laryngoscope 3 2004 393 402
32. R.M. Tuttle, R. Loeboeuf, and A.R. Shaha Medical management of thyroid cancer: a risk adapted approach J Surg Oncol 15 2008 712 716
33. A.R. Shaha, J.P. Shah, and T.R. Loree Low-risk differentiated thyroid cancer: the need for selective treatment Ann Surgic Oncol 4 1997 328 333
34. R. Udelsman, and A.R. Shaha Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer? Lancet Oncol 6 2005 529 532
35. H.W. Lin, and N. Bhattacharyya Survival impact of treatment options for papillary microcarcinoma of the thyroid Laryngoscope 119 2009 1983 1987
36. E. Roti, E.C. Uberti, M. Bondanelli, and L.E. Braverman Thyroid papillary microcarcinoma: a descriptive and meta-analysis study Eur J Endocrinol 159 2008 659 673
37. F. Vaisman, A. Shaha, S. Fish, and R. Tuttle Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiates thyroid cancer Clin Endocrinol (Oxf) 75 2011 112 119
38. M.D. Nixon, I. Ganly, S.G. Patel, F.L. Palmer, M.M. Whitcher, and R.M. Tuttle Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy Surgery 151 2012 571 579
39. I.J. Nixon, F.L. Palmer, M.M. Whitcher, A.R. Shaha, J.P. Shah, and S.G. Patel Thyroid isthmusectomy for well-differentiated thyroid cancer Ann Surg Oncol 18 2011 767 770
40. P.I. Haigh, D.R. Urbach, and L.E. Rostein Extent of thyroidectomy is not a major determinant of survival in low- or high-risk thyroid cancer Ann Surg Oncol 12 2005 81 89
41. E.L. Mazzaferri A vision of the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissection and selective use of radioiodine J Clin Endocrinol Metab 94 2009 1086 1088
42. E.L. Mazzaferri, G.E. Doherty, and D.L. Steward The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma Thyroid 19 2009 683 688
43. A.R. Shaha Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate Surgery 146 2009 1224 1227
44. S. Bonnet, D. Hartl, S. Leboulleux, E. Baudin, J.D. Lumbroso, and A. Al Ghunzlan Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment J Clin Endocrinol Metab 94 2009 1162 1167
45. D.M. Hartl, S. Leboulleux, A. Al Ghuzlan, E. Baudin, L. Chami, and M. Schlumberger Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma Ann Surg 255 2012 777 783
46. D. Van Nostrand, and L. Wartofsky Radioiodine in the treatment of thyroid cancer Endocrinol Metab Clin N Am 36 2007 807 822
47. E. Mazzaferi Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma Thyroid 7 1997 265 271
48. W. Sacks, C.H. Fung, A. Waxman, and G.D. Braunstein Effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008 Thyroid 20 2010 1235 1245